PARIS, April 12 (Reuters) - Sanofi-Aventis (SASY.PA: Quote, Profile, Research) is to retrieve all rights to its anti-obesity pill Acomplia in Japan from Astellas Pharma as part of its aim to strengthen its presence in the country, the world’s third largest drugmaker said on Wednesday.
